GDF15 in Anorexia Nervosa

Elevated Plasma GDF15 Combined With FGF21 Suggests Mitochondrial Dysfunction in a Subgroup of Anorexia Nervosa Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07016347

Enrollment

200

Registered

2025-06-11

Start date

2017-01-23

Completion date

2024-11-04

Last updated

2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa

Brief summary

Evaluating plasma levels of a protein called GDF15 in active and recovered anorexia nervosa, as well as healthy controls

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- active DSMV diagnosis of anorexia nervosa/ at least two years of recovery from DSMV anorexia nervosa / no history of anorexia nervosa

Exclusion criteria

\- male

Design outcomes

Primary

Measure	Time frame
plasma GDF15	At baseline

Countries

Sweden

Outcome results